Snake venom drug tried in advanced cancer patients
NCT ID NCT01481532
First seen Apr 10, 2026 · Last updated Apr 25, 2026 · Updated 4 times
Summary
This early-phase trial tests a protein from snake venom (crotoxin) given through a vein to people with advanced solid tumors. The main goal is to see if patients can safely tolerate higher doses without severe side effects. About 24 adults whose cancer has not responded to standard treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de Cancérologie de l'Ouest
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.